Skip to main content

Table 2 VDR, RXR and PPARγ immunopositivity in breast cancer subgroups

From: Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis

 

VDR (median IRS)

RXR (median IRS)

PPARγ (median IRS)

 

BRCA1 mut

sporadic

p

BRCA1 mut

sporadic

p

BRCA1 mut

sporadic

p

Luminal A

3,5

1,0

0,142

6,0

4,0

0,223

1,5

0,0

0,002

Luminal B

8,0

3,5

0,026

6,0

3,5

0,23

1,0

0,0

0,032

Her2 positive

8,0

4,0

0,023

4,5

4,0

0,769

1,0

0,0

0,061

TNBC

8,0

3,0

0,003

8,0

2,5

0,036

6,0

2,0

0,072

  1. Median VDR, RXR and PPARγ immunopositivity was analyzed in breast cancer subtypes.
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us